As part of our series focussing on medicines available in Australia, we have added a product review of the use of MF59-Adjuvanted inactivated influenza vaccines in protecting older adults against seasonal influenza.
This review discusses indications, pharmacological properties, contraindications and a series of clinical studies featuring the vaccine. It provides commentary from Dr Paul Van Buynder, a Public Health Physician and Professor at the School of Medicine at Griffith University.
Please login below to download this issue (PDF)